1. Home
  2. BBLG vs CRIS Comparison

BBLG vs CRIS Comparison

Compare BBLG & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBLG

Bone Biologics Corp

N/A

Current Price

$0.28

Market Cap

1.2M

Sector

Health Care

ML Signal

N/A

Logo Curis Inc.

CRIS

Curis Inc.

N/A

Current Price

$0.47

Market Cap

976.1K

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBLG
CRIS
Founded
2004
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2M
976.1K
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
BBLG
CRIS
Price
$0.28
$0.47
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $30.33
AVG Volume (30 Days)
409.0K
★ 5.9M
Earning Date
10-26-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
45.13
★ 91.57
EPS
★ N/A
N/A
Revenue
★ $1,070,000,000.00
$9,898,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$604.76
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 31.50
52 Week Low
$0.27
$0.33
52 Week High
$4.78
$2,880.00

Technical Indicators

Market Signals
Indicator
BBLG
CRIS
Relative Strength Index (RSI) 28.94 33.16
Support Level N/A $0.33
Resistance Level $0.48 $1.60
Average True Range (ATR) 0.05 0.21
MACD 0.01 0.15
Stochastic Oscillator 10.91 7.04

Price Performance

Historical Comparison
BBLG
CRIS

About BBLG Bone Biologics Corp

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: